How AI Is Changing the Economics of Drug Discovery

June 29, 2026

Following FDA hold, Aardvark will examine phase 3 data early

May 19, 2026

Inhibrx Reports Higher Response Rate for INBRX-106 and Keytruda in Midphase Head and Neck Cancer Trial

May 12, 2026

Must Read

The Science Behind Bispecific Antibodies and Their Therapeutic Potential

November 12, 2026

Top 10 Emerging Technologies in Microbial Biotechnology

November 12, 2026

Delix Therapeutics Raises $100 Million to Advance Zalsupindole for Depression

November 12, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Argenx Scraps Phase III Sjögren Study Over Predicted Efficacy Failure

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

Cloudbreak Pharma’s CBT-001 Meets Phase 3 Endpoints in Pterygium Trial

Neurocrine Plans Vykat Safety Study After Reports of Patient Deaths

Phase 3 psoriasis victory: China’s InventisBio provides competitive TYK2 data

Teva Discontinues Phase 2 Emrusolmin Trial for Multiple System Atrophy

Delix Therapeutics Raises $100 Million to Advance Zalsupindole for Depression

AstraZeneca reportedly made a $10 billion deal for the sought-after metabolic jewel Rhythm

Evommune Secures Huge Hinova Deal for Oral Autoimmune Drug

Vera Health Raises $28.5 Million to Expand Clinical AI Search Platform

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The Science Behind Bispecific Antibodies and Their Therapeutic Potential

Top 10 Emerging Technologies in Microbial Biotechnology

Top 10 Factors That Influence Clinical Trial Protocol Complexity

Risk-Based Monitoring Reimagined: The Next Evolution of Clinical Trial Oversight

Tag: Biotechnology

Eli Lilly’s VERVE-102 Shows Up to 62% LDL Cholesterol Reduction in Early Trial

Editor Picks

How AI Is Changing the Economics of Drug Discovery

Following FDA hold, Aardvark will examine phase 3 data early

Inhibrx Reports Higher Response Rate for INBRX-106 and Keytruda in Midphase Head and Neck Cancer Trial

Must Read

The Science Behind Bispecific Antibodies and Their Therapeutic Potential

Top 10 Emerging Technologies in Microbial Biotechnology

Delix Therapeutics Raises $100 Million to Advance Zalsupindole for Depression

Hot Topics

About Us

Follow Us

Top Industry Leaders Award 2026